Zearalenone promotes hepatic lipid accumulation via EGFR-HSP90 complex stabilization.
Collectively, ZEA promotes hepatic lipid accumulation via stabilization of the EGFR-HSP90 complex and activation of the EGFR-SREBP1c axis, suggesting EGFR as a potential therapeutic target.